Report Detail

Request for Sample of this report

Agriculture Global Pet Antibiotic Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4737426
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Agriculture

According to our (Global Info Research) latest study, the global Pet Antibiotic market size was valued at US$ 1571 million in 2025 and is forecast to a readjusted size of US$ 2353 million by 2032 with a CAGR of 6.1% during review period.
Pet Antibiotics are antimicrobial pharmaceutical compounds formulated for companion animals such as dogs, cats, and small mammals to prevent, control, and treat bacterial infections affecting skin, respiratory system, urinary tract, gastrointestinal system, and post-surgical wounds, while ensuring safety, dosage precision, and palatability for non-livestock domestic animal use under veterinary supervision.
The Pet Antibiotic industry chain consists of upstream pharmaceutical raw material suppliers producing active pharmaceutical ingredients such as tetracyclines, macrolides, fluoroquinolones, and beta-lactams through fermentation or chemical synthesis along with excipients, flavoring agents, and formulation additives, while midstream manufacturers develop, formulate, and package antibiotics into tablets, injectables, suspensions, and topical products under strict veterinary pharmaceutical quality standards, and downstream distribution channels including veterinary hospitals, clinics, pet pharmacies, online platforms, and pet care providers deliver these products to pet owners and animal shelters for treatment of bacterial infections, post-surgical care, and preventive infection management in companion animals.
Pet Antibiotic projects under construction and planned are primarily driven by expansion in companion animal healthcare infrastructure, increasing pet ownership rates, and rising demand for advanced veterinary pharmaceuticals in North America, Europe, and Asia-Pacific, with investments focusing on new production lines for palatable oral formulations, injectable sterile facilities, and topical antibiotic manufacturing units, alongside digital veterinary pharmacy expansion and online distribution integration, while emerging markets are developing localized veterinary drug production capacity, supported by pet insurance growth, veterinary clinic network expansion, and stricter regulatory compliance frameworks for antimicrobial usage in companion animals and improved drug safety standards.
2025 Global Market Average Gross Profit Margin: 35%.
The pet antibiotic market is a growing niche within the broader veterinary pharmaceutical industry, driven by rising global pet ownership and increasing expenditure on companion animal healthcare. Demand is strongly influenced by urbanization and the humanization of pets, where owners prioritize advanced medical treatment for dogs and cats. Veterinary clinics remain the dominant distribution and prescription channel. North America and Europe are the most mature markets due to high veterinary care penetration and strong regulatory frameworks.
Asia-Pacific is emerging as a fast-growing region supported by expanding pet populations in China, Japan, and South Korea. The market is characterized by high-value, low-volume consumption compared to livestock antibiotics. Oral formulations such as tablets and flavored suspensions dominate due to ease of administration. Skin and respiratory infections represent the most common application areas. Regulatory oversight is stricter than livestock antibiotics, with prescription-only controls in most developed markets. Innovation is focused on palatable formulations to improve compliance in pets. Pharmaceutical companies are increasingly integrating antibiotics into broader companion animal therapeutic portfolios. E-commerce and online veterinary pharmacies are becoming important growth channels. Rising awareness of antimicrobial resistance is gradually shaping prescription behavior among veterinarians. Competitive dynamics are moderately consolidated, with global animal health companies and specialized veterinary drug manufacturers leading the market.
Overall, the market is transitioning toward precision, safety-focused, and pet-friendly antibiotic solutions supported by expanding veterinary healthcare infrastructure.
This report is a detailed and comprehensive analysis for global Pet Antibiotic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pet Antibiotic market size and forecasts, in consumption value ($ Million), 2021-2032
Global Pet Antibiotic market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Pet Antibiotic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Pet Antibiotic market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pet Antibiotic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pet Antibiotic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, Huvepharma, Virbac, Vetoquinol, Pharmgate Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pet Antibiotic market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tetracyclines
Macrolides
Beta-Lactams
Aminoglycosides
Others
Market segment by Mode Of Action Type
Bacteriostatic
Bactericidal
Others
Market segment by Formulation Type
Oral Tablet
Injectable
Liquid Suspension
Topical Ointment
Market segment by Application
Dog
Cat
Small Mammal
Exotic
Market segment by players, this report covers
Zoetis Inc.
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
Ceva Santé Animale
Phibro Animal Health Corporation
Huvepharma
Virbac
Vetoquinol
Pharmgate Animal Health
Norbrook Laboratories
Dechra Pharmaceuticals
Zydus Animal Health
Zhejiang Hisun Pharmaceutical Co
Hunan Weida Technology Co
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pet Antibiotic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pet Antibiotic, with revenue, gross margin, and global market share of Pet Antibiotic from 2021 to 2026.
Chapter 3, the Pet Antibiotic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pet Antibiotic market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Antibiotic.
Chapter 13, to describe Pet Antibiotic research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pet Antibiotic by Type
    • 1.3.1 Overview: Global Pet Antibiotic Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Pet Antibiotic Consumption Value Market Share by Type in 2025
    • 1.3.3 Tetracyclines
    • 1.3.4 Macrolides
    • 1.3.5 Beta-Lactams
    • 1.3.6 Aminoglycosides
    • 1.3.7 Others
  • 1.4 Classification of Pet Antibiotic by Mode Of Action Type
    • 1.4.1 Overview: Global Pet Antibiotic Market Size by Mode Of Action Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Pet Antibiotic Consumption Value Market Share by Mode Of Action Type in 2025
    • 1.4.3 Bacteriostatic
    • 1.4.4 Bactericidal
    • 1.4.5 Others
  • 1.5 Classification of Pet Antibiotic by Formulation Type
    • 1.5.1 Overview: Global Pet Antibiotic Market Size by Formulation Type: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Pet Antibiotic Consumption Value Market Share by Formulation Type in 2025
    • 1.5.3 Oral Tablet
    • 1.5.4 Injectable
    • 1.5.5 Liquid Suspension
    • 1.5.6 Topical Ointment
  • 1.6 Global Pet Antibiotic Market by Application
    • 1.6.1 Overview: Global Pet Antibiotic Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Dog
    • 1.6.3 Cat
    • 1.6.4 Small Mammal
    • 1.6.5 Exotic
  • 1.7 Global Pet Antibiotic Market Size & Forecast
  • 1.8 Global Pet Antibiotic Market Size and Forecast by Region
    • 1.8.1 Global Pet Antibiotic Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Pet Antibiotic Market Size by Region, (2021-2032)
    • 1.8.3 North America Pet Antibiotic Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Pet Antibiotic Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Pet Antibiotic Market Size and Prospect (2021-2032)
    • 1.8.6 South America Pet Antibiotic Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Pet Antibiotic Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Zoetis Inc.
    • 2.1.1 Zoetis Inc. Details
    • 2.1.2 Zoetis Inc. Major Business
    • 2.1.3 Zoetis Inc. Pet Antibiotic Product and Solutions
    • 2.1.4 Zoetis Inc. Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zoetis Inc. Recent Developments and Future Plans
  • 2.2 Elanco Animal Health
    • 2.2.1 Elanco Animal Health Details
    • 2.2.2 Elanco Animal Health Major Business
    • 2.2.3 Elanco Animal Health Pet Antibiotic Product and Solutions
    • 2.2.4 Elanco Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Elanco Animal Health Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim Animal Health
    • 2.3.1 Boehringer Ingelheim Animal Health Details
    • 2.3.2 Boehringer Ingelheim Animal Health Major Business
    • 2.3.3 Boehringer Ingelheim Animal Health Pet Antibiotic Product and Solutions
    • 2.3.4 Boehringer Ingelheim Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim Animal Health Recent Developments and Future Plans
  • 2.4 Merck Animal Health
    • 2.4.1 Merck Animal Health Details
    • 2.4.2 Merck Animal Health Major Business
    • 2.4.3 Merck Animal Health Pet Antibiotic Product and Solutions
    • 2.4.4 Merck Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Merck Animal Health Recent Developments and Future Plans
  • 2.5 Ceva Santé Animale
    • 2.5.1 Ceva Santé Animale Details
    • 2.5.2 Ceva Santé Animale Major Business
    • 2.5.3 Ceva Santé Animale Pet Antibiotic Product and Solutions
    • 2.5.4 Ceva Santé Animale Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Ceva Santé Animale Recent Developments and Future Plans
  • 2.6 Phibro Animal Health Corporation
    • 2.6.1 Phibro Animal Health Corporation Details
    • 2.6.2 Phibro Animal Health Corporation Major Business
    • 2.6.3 Phibro Animal Health Corporation Pet Antibiotic Product and Solutions
    • 2.6.4 Phibro Animal Health Corporation Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Phibro Animal Health Corporation Recent Developments and Future Plans
  • 2.7 Huvepharma
    • 2.7.1 Huvepharma Details
    • 2.7.2 Huvepharma Major Business
    • 2.7.3 Huvepharma Pet Antibiotic Product and Solutions
    • 2.7.4 Huvepharma Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Huvepharma Recent Developments and Future Plans
  • 2.8 Virbac
    • 2.8.1 Virbac Details
    • 2.8.2 Virbac Major Business
    • 2.8.3 Virbac Pet Antibiotic Product and Solutions
    • 2.8.4 Virbac Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Virbac Recent Developments and Future Plans
  • 2.9 Vetoquinol
    • 2.9.1 Vetoquinol Details
    • 2.9.2 Vetoquinol Major Business
    • 2.9.3 Vetoquinol Pet Antibiotic Product and Solutions
    • 2.9.4 Vetoquinol Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Vetoquinol Recent Developments and Future Plans
  • 2.10 Pharmgate Animal Health
    • 2.10.1 Pharmgate Animal Health Details
    • 2.10.2 Pharmgate Animal Health Major Business
    • 2.10.3 Pharmgate Animal Health Pet Antibiotic Product and Solutions
    • 2.10.4 Pharmgate Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Pharmgate Animal Health Recent Developments and Future Plans
  • 2.11 Norbrook Laboratories
    • 2.11.1 Norbrook Laboratories Details
    • 2.11.2 Norbrook Laboratories Major Business
    • 2.11.3 Norbrook Laboratories Pet Antibiotic Product and Solutions
    • 2.11.4 Norbrook Laboratories Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Norbrook Laboratories Recent Developments and Future Plans
  • 2.12 Dechra Pharmaceuticals
    • 2.12.1 Dechra Pharmaceuticals Details
    • 2.12.2 Dechra Pharmaceuticals Major Business
    • 2.12.3 Dechra Pharmaceuticals Pet Antibiotic Product and Solutions
    • 2.12.4 Dechra Pharmaceuticals Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Dechra Pharmaceuticals Recent Developments and Future Plans
  • 2.13 Zydus Animal Health
    • 2.13.1 Zydus Animal Health Details
    • 2.13.2 Zydus Animal Health Major Business
    • 2.13.3 Zydus Animal Health Pet Antibiotic Product and Solutions
    • 2.13.4 Zydus Animal Health Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Zydus Animal Health Recent Developments and Future Plans
  • 2.14 Zhejiang Hisun Pharmaceutical Co
    • 2.14.1 Zhejiang Hisun Pharmaceutical Co Details
    • 2.14.2 Zhejiang Hisun Pharmaceutical Co Major Business
    • 2.14.3 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Product and Solutions
    • 2.14.4 Zhejiang Hisun Pharmaceutical Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zhejiang Hisun Pharmaceutical Co Recent Developments and Future Plans
  • 2.15 Hunan Weida Technology Co
    • 2.15.1 Hunan Weida Technology Co Details
    • 2.15.2 Hunan Weida Technology Co Major Business
    • 2.15.3 Hunan Weida Technology Co Pet Antibiotic Product and Solutions
    • 2.15.4 Hunan Weida Technology Co Pet Antibiotic Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hunan Weida Technology Co Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pet Antibiotic Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Pet Antibiotic by Company Revenue
    • 3.2.2 Top 3 Pet Antibiotic Players Market Share in 2025
    • 3.2.3 Top 6 Pet Antibiotic Players Market Share in 2025
  • 3.3 Pet Antibiotic Market: Overall Company Footprint Analysis
    • 3.3.1 Pet Antibiotic Market: Region Footprint
    • 3.3.2 Pet Antibiotic Market: Company Product Type Footprint
    • 3.3.3 Pet Antibiotic Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pet Antibiotic Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Pet Antibiotic Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Pet Antibiotic Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Pet Antibiotic Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Pet Antibiotic Consumption Value by Type (2021-2032)
  • 6.2 North America Pet Antibiotic Market Size by Application (2021-2032)
  • 6.3 North America Pet Antibiotic Market Size by Country
    • 6.3.1 North America Pet Antibiotic Consumption Value by Country (2021-2032)
    • 6.3.2 United States Pet Antibiotic Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Pet Antibiotic Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Pet Antibiotic Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Pet Antibiotic Consumption Value by Type (2021-2032)
  • 7.2 Europe Pet Antibiotic Consumption Value by Application (2021-2032)
  • 7.3 Europe Pet Antibiotic Market Size by Country
    • 7.3.1 Europe Pet Antibiotic Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Pet Antibiotic Market Size and Forecast (2021-2032)
    • 7.3.3 France Pet Antibiotic Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Pet Antibiotic Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Pet Antibiotic Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Pet Antibiotic Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pet Antibiotic Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Pet Antibiotic Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Pet Antibiotic Market Size by Region
    • 8.3.1 Asia-Pacific Pet Antibiotic Consumption Value by Region (2021-2032)
    • 8.3.2 China Pet Antibiotic Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Pet Antibiotic Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Pet Antibiotic Market Size and Forecast (2021-2032)
    • 8.3.5 India Pet Antibiotic Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Pet Antibiotic Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Pet Antibiotic Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Pet Antibiotic Consumption Value by Type (2021-2032)
  • 9.2 South America Pet Antibiotic Consumption Value by Application (2021-2032)
  • 9.3 South America Pet Antibiotic Market Size by Country
    • 9.3.1 South America Pet Antibiotic Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Pet Antibiotic Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Pet Antibiotic Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pet Antibiotic Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Pet Antibiotic Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Pet Antibiotic Market Size by Country
    • 10.3.1 Middle East & Africa Pet Antibiotic Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Pet Antibiotic Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Pet Antibiotic Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Pet Antibiotic Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Pet Antibiotic Market Drivers
  • 11.2 Pet Antibiotic Market Restraints
  • 11.3 Pet Antibiotic Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pet Antibiotic Industry Chain
  • 12.2 Pet Antibiotic Upstream Analysis
  • 12.3 Pet Antibiotic Midstream Analysis
  • 12.4 Pet Antibiotic Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pet Antibiotic. Industry analysis & Market Report on Pet Antibiotic is a syndicated market report, published as Global Pet Antibiotic Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pet Antibiotic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo